CONTEXT THERAPEUTICS INC. Shareholders' Equity
CONTEXT THERAPEUTICS INC. (CNTX) had Shareholders' Equity of $38.17 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $38.17M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $52.20M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $60.47M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $73.17M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $38.17M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $52.20M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $60.47M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $73.17M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $82.54M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $90.98M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $95.27M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $83.86M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $101.10M 10-Q · filed 2025-11-05 |
| 2024-03-31 | $8.44M 10-Q · filed 2025-11-05 |
| 2023-12-31 | $11.87M 10-K · filed 2026-03-23 |
| 2023-09-30 | $18.38M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $24.00M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $28.73M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $34.76M 10-K · filed 2025-03-20 |
| 2022-09-30 | $38.07M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $41.65M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $45.39M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $48.27M 10-K · filed 2024-03-21 |
| 2021-09-30 | -$23.21M 10-Q · filed 2022-11-09 |
| 2021-06-30 | -$22.30M 10-Q · filed 2022-11-09 |
| 2021-03-31 | -$17.48M 10-Q · filed 2022-11-09 |
| 2020-12-31 | -$16.92M 10-K · filed 2023-03-22 |
| 2020-09-30 | -$16.22M 10-Q · filed 2021-12-02 |
| 2020-06-30 | -$15.39M 10-Q · filed 2021-12-02 |
| 2020-03-31 | -$22.99M 10-Q · filed 2021-12-02 |
| 2019-12-31 | -$23.96M 10-K · filed 2022-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |